Sign in Sign up for free

Last updated: 29 May 2022 at 7:44am EST

Franklin Salisbury Net Worth



Franklin Salisbury biography

Franklin C. Salisbury Jr. serves as Independent Director of the Company. Mr. Salisbury has been a director of the Company since June 2014. Mr. Salisbury is a co-founder and director of AIM-HI Translational Research, a nonprofit accelerator fund which is an extension of NFCR. Prior to AIM-HI, Mr. Salisbury was Chief Executive Officer of the National Foundation for Cancer Research (NFCR) from 1998-2018. NFCR is an organization that supports basic science research at universities and research hospitals in order to accelerate new approaches to preventing, diagnosing and treating cancer. Under his leadership, NFCR has forged greater collaboration among scientists at universities, research hospitals, and pharmaceutical companies in the U.S. and China in an effort to bring new and innovative care to cancer patients. Mr. Salisbury also led NFCR to launch several research consortia that have enabled cancer researchers to pool their resources and reduce duplicate efforts, thereby accelerating discoveries being made and reducing the cost of achieving them. Mr. Salisbury also holds a B.A. in economics from Yale, a Juris Doctor, J.D., from the University of Georgia School of Law, a Masters of the Arts degree from the University of Chicago, and an M.Div. from Yale Divinity School.

What is the salary of Franklin Salisbury?

As the Independent Director of CASI Pharmaceuticals Inc, the total compensation of Franklin Salisbury at CASI Pharmaceuticals Inc is $140,450. There are 7 executives at CASI Pharmaceuticals Inc getting paid more, with Wei-Wu He having the highest compensation of $9,269,690.



How old is Franklin Salisbury?

Franklin Salisbury is 64, he's been the Independent Director of CASI Pharmaceuticals Inc since 2014. There are 1 older and 9 younger executives at CASI Pharmaceuticals Inc. The oldest executive at CASI Pharmaceuticals Inc is Rajesh Shrotriya, 76, who is the Independent Director.

What's Franklin Salisbury's mailing address?

Franklin's mailing address filed with the SEC is CASI PHARMACEUTICALS, INC., 9620 MEDICAL CENTER DR. SUITE 300, ROCKVILLE, MD, 20850.

Insiders trading at CASI Pharmaceuticals Inc

Over the last 12 years, insiders at CASI Pharmaceuticals Inc have traded over $0 worth of CASI Pharmaceuticals Inc stock and bought 30,834,178 units worth $51,898,666 . The most active insiders traders include Wei Wu He, Rajesh C Md Shrotriya, and Pharmaceuticals Inc Spectru.... On average, CASI Pharmaceuticals Inc executives and independent directors trade stock every 91 days with the average trade being worth of $6,141,555. The most recent stock trade was executed by James Huang on 6 September 2022, trading 55,573 units of CASI stock currently worth $229,516.



What does CASI Pharmaceuticals Inc do?

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.



What does CASI Pharmaceuticals Inc's logo look like?

CASI Pharmaceuticals Inc logo

CASI Pharmaceuticals Inc executives and stock owners

CASI Pharmaceuticals Inc executives and other stock owners filed with the SEC include: